Dogs land FDA ruling on joining owners outdoors at restaurants

Brasil Notícia Notícia

Dogs land FDA ruling on joining owners outdoors at restaurants
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 nypost
  • ⏱ Reading Time:
  • 56 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 67%

Could your dining party be upped by one for your next al fresco restaurant visit?

The Food and Drug Administration recently updated theirto allow “pet dogs” — not just service animals — “in outdoor dining areas, where approved.”

Restaurants, bars and cafes can still make their own decisions on whether or not they want to have tails waggingBut if an establishment permits a small, shivering chihuahua onto their patio, staff also has welcome a large, drooling Great Dane — discriminating based on breed is prohibited.Restaurants, bars and cafes are still allowed to make their own rules about whether or not they want to welcome pets.

Service animals have almost always been permitted to join their owners at meals, but the difference between a certified service animal and a cuddly pet has led to years of confusion.During the summer of 2019, the NYC Commission of Human Rights issued a new set of legal guidelines regarding people with disabilities, one of which reminded restaurants that they are forbidden to demand proof of either a person’s disability or an animal’s use as a service companion.

“It’s gross,” Danit Sibovits, an Upper West Side lawyer, previously told The Post. “I don’t want dog hair or slobber near my food.”“I can’t say, ‘Excuse me, can I see ID for this dog?’ It’s like profiling,” he said.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

nypost /  🏆 91. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

FDA grants accelerated approval to Biogen treatment for rare form of ALSFDA grants accelerated approval to Biogen treatment for rare form of ALSThe FDA has deemed Biogen's torferson reasonably likely to produce a clinical benefit for patients.
Consulte Mais informação »

FDNY goes high-tech as it unveils its new robot ‘dogs’ and dronesFDNY goes high-tech as it unveils its new robot ‘dogs’ and dronesMayor Eric Adams and FDNY Commissioner Laura Kavanagh were on hand for a demonstration of the department's new technology — including drones and robot 'dogs.'
Consulte Mais informação »

Robotic dogs, drones put into action in Lower Manhattan parking garage collapseRobotic dogs, drones put into action in Lower Manhattan parking garage collapseOne week after the deadly garage collapse in Lower Manhattan that left one dead and several others injured, we are learning more about the technology used by first responders to help save lives when time was of the essence.
Consulte Mais informação »

Extra Extra: FDA says it's okay to bring your dog to outdoor diningExtra Extra: FDA says it's okay to bring your dog to outdoor diningBecause the weather is not too hot, but not too cold, here are your evening links: —FDA guidance says you can bring your dog to outdoor dining —Timothée Chalamet films a cologne commercial inside a subway car —'Jaws' is coming to Broadway, kinda +more!
Consulte Mais informação »

Bluebird Bio Submits FDA Application for Gene TherapyBluebird Bio Submits FDA Application for Gene TherapyBluebird bio said on Monday it has submitted a marketing application to the Food and Drug Administration for its gene therapy to treat sickle cell disease.
Consulte Mais informação »

Drug for rare form of Lou Gehrig’s disease OK'd by FDADrug for rare form of Lou Gehrig’s disease OK'd by FDAU.S. health regulators have approved a first-of-a-kind drug for a rare form of Lou Gehrig’s disease. The Food and Drug Administration approved Biogen's infused drug for patients with a rare genetic mutation that affects less than 500 people in the U.S. The drug is the first intended to treat an inherited form of ALS, or amyotrophic lateral sclerosis, which destroys nerve cells needed for basic functions. Tuesday's approval came despite a company study that failed to meet its goal of significantly slowing the disease. The drug did make a difference on laboratory measures of ALS. The FDA is requiring additional research to confirm the drug's benefit.
Consulte Mais informação »



Render Time: 2025-03-01 04:01:28